Influvac tetra is a quadrivalent influenza vaccine used to prevent seasonal flu by protecting against four different virus strains, invigorating the body to build immunity and reducing the risk of femanisation ,complications ,hospitalizations and severe illness, especially for high-risk groups like the elderly, young children, and people with chronic conditions. Administered as an annual intramuscular injection, it works best before flu begins and does not treat existing infection.

Annual flu vaccination is essential because influenza viruses mutate constantly, rending previous immunity ineffective, and because fades over time. An annual shots updates one’s immunity to target latest circulatory stains ,significantly reducing the risk of severe illness ,hospitalization and death. It also protects vulnerable populations, such as young children and elderly.

     Annual flu vaccination is important because of the following reasons:

Viruses Evolve: The flu virus changes, and vaccines are updated annually to match the strains predicted to circulate.

Immunity fades: protection from the flu vaccine acknowledge over time ,necessitating an annual booster.

Reduces severity : if one get the flu, the vaccine can significantly lessen symptoms ,shorten the duration and prevent complications.

Protects others : vaccinated individuals are less likely to spread virus to vulnerable people like infants, the elderly, and those with chronic conditions.

Reduces healthcare burden : high vaccination rates decrease the number of hospitalizations, easing pressure on medical systems.

Diseases which are protected by influvac tetra vaccine are :

      Influvac Tetra is a quadrivalent inactivated vaccine that protects against four seasonal influenza strains (two A strains and two B strains ) ,reducing the risk of infection ,severity of illness, and related complications. It is recommended annually for adults and children (6 months) .peak immunity occurs 2 weeks post-vaccination.

Protection : it helps the body produce antibodies against specific influenza virus strains lowering the risk of severe illness and complications

Targeted strains : The 2025/2026 vaccine aligns with WHO recommendations to cover four common influenza strains.

Target population: particularly beneficial for high-risk groups, including the elderly, young children ,pregnant women and those with chronic conditions

Duration: the vaccine offers protection for the duration of the flu season, but it is necessary to receive it annually as strain change.

Administration: it is given as 0.5 ml injection ,usually in the arm.

Side effects: mild ,temporary side effects may occur, such as pain at the injection site, headache, fever, fatigue and muscle pain.

 COMPLICATIONS SUCH AS PNEUMONIA 

Influvac tetra is a quadrivalent influenza vaccine that provides indirect protection against pneumonia by preventing severe influenza infections ,a leading cause of secondary pneumonia. It reduces the risk of hospitalization and severe complications ,particularly in the elderly ,young children and those with chronic conditions ,by covering four circulatory strains.

Preventing complications : pneumonia is a common complication of influenza ,affecting 30-40% of hospitalized influenza patients. By preventing the flu, the vaccine reduces the likelihood of this secondary bacterial pneumonia.

Targeted protection: the vaccine covers two influenza A strains (H1N1,H3N2) and two influenza B strains ,which are the viruses that often lead to severe pulmonary complications.

Recommended population: it is especially deceive for individuals at high risk for pneumonia ,such as adults over 65 ,young-children and people with chronic illness .

Duration: the vaccine needs to be administered annually as circulating influenza strains change and immunity wanes.

 It is advised to consult a healthcare professional regarding your vaccination schedule, particularly if you have allergies to eggs or other vaccine components.

Influvac tetra is an inactivated (dead) quadrivalent vaccine that prevents influenza by training the immune system to recognize and fight for specific virus strains . it works by introducing surface antigens ,primarily hemagglutinin, which promote the body to produce protective antibodies without causing illness.

Following are the ways of working influvac Tetra :

Immune system stimulation: once injected, the vaccines inactive virus fragments stimulate the immune system to produce antibodies.

Antibody Development: These antibodies are designed to recognize the specific influenza strain included in the vaccine.

Future protection: if one are later exposed to these viruses ,the prepared antibodies recognize and destroy the virus if exposure occurs in the future.

Annual update: Because flu viruses change, the vaccine composition is updated annually to match the strains circulating in the upcoming season.

Key facts:

Targeted protection: it is designed for active immunization to prevent influenza in adults and children from 6 months of age.

Effectiveness : it helps reduce the risk of contracting the flu, lessens severity if infection occurs, and reduces complications.

Administration: it is administered via intramuscular injection usually before start of flu season.

Side effects: common reactions include soreness at the injection site, headache ,fever and fatigue

 WHAT ARE THE BENEFITS OF INFLUVAC TETRA VACCINATION?

Benefits of Influvac Tetra vaccination are :

 BROAD PROTECTION AGAINST FOUR STRAINS 

         Influvac Tera is a quadrivalent inactivated vaccine that provides comprehensive protection against seasonal influenza by targeting two influenza A strains (H1N1 and H3N2) and two influenza B lineages .

    REDUCES SEVERITY AND COMPLICATIONS

       The primary benefit of the influvac Tetra vaccine is to provide active immunisation against flu virus ,which includes significantly reducing the severity of illness and risk of serious complications like pneumonia and hospitalization.

       Influvac tetra is widely recognized for its safety profile, effectiveness and high tolerably across various age groups , including children (6 months and older ), adults and the elderly.

     It is a critical preventive measure for vulnerable population ,as it helps reduce the risk of severe complications, hospitalization and death during the flu season.

CONCLUSION: Influvac Tetra vaccination is a critical tool for influenza prevention due to its board ,quadrivalent and inactivated nature. It is particularly important for high-risk individuals like elderly, young children over 6 months and those with chronic health conditions -because it provides comprehensive protection against four distinct circulating flu strains . in 2025/2026, influvac tetra offers a safe, clinically proven, and reliable method to prevent influenza, reduce hospitalization, and minimize morality by providing broad, updated and targeted protection.

 QUESTION: IS FLU VACCINE NEEDED EVERY YEAR?

 Yes, an annual flu vaccine is recommended for everyone 6 months and older because influenza viruses evolve rapidly, rending previous vaccines less effective.

 Yes, the influvac tetra vaccine can be given at the same time as other vaccines ,including covid-19, or pneumococcal vaccines. When co-administrated , they should be injected into different limbs. While safe, receiving multiple vaccines simultaneously might slightly increase the likelihood for stronger, temporary side effects.

No, the Influvac tetra vaccine cannot prevent covid-19 infection itself, as it is specifically designed to protect against four different seasonal influenza viruses. However, some studies indicate that receiving an influenza vaccine such as influvac tetra, may offer some indirect or partial benefits in the context of covid- 19 pandemic.

REFRENCES: